158 related articles for article (PubMed ID: 20622324)
1. Clinical characteristics and therapeutic analysis of invasive fungal infection in chronic severe hepatitis patients.
Hou Z; Tan D; Liu G; Xie Y; Li C; Xie J; Lu M; Liu Z; Sha X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Jun; 35(6):537-42. PubMed ID: 20622324
[TBL] [Abstract][Full Text] [Related]
2. [Clinical features and treatment of invasive fungal infection in 47 patients with hematological malignancies].
Zhu Y; Chen SP; Shu YG; Xu YJ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 33(1):89-92. PubMed ID: 18245913
[TBL] [Abstract][Full Text] [Related]
3. Focus on fungal infections.
MacDougall DS
J Int Assoc Physicians AIDS Care; 1997 Jul; 3(7):27-32. PubMed ID: 11364470
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and treatment of invasive fungal infections in the cancer patient: recent progress and ongoing questions.
Kontoyiannis DP; Patterson TF
Clin Infect Dis; 2014 Nov; 59 Suppl 5(Suppl 5):S356-9. PubMed ID: 25352631
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of invasive fungal infections with voriconazole. Evaluation of experience with compassionate use of voriconazole in Spain].
Díaz Pedroche C; Cisneros JM; Lumbreras C; Aguado JM;
Rev Esp Quimioter; 2005 Jun; 18(2):149-58. PubMed ID: 16130037
[TBL] [Abstract][Full Text] [Related]
6. Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey.
Sinkó J; Csomor J; Nikolova R; Lueff S; Kriván G; Reményi P; Bátai A; Masszi T
Transpl Infect Dis; 2008 Apr; 10(2):106-9. PubMed ID: 17605727
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
[TBL] [Abstract][Full Text] [Related]
8. Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.
Prescrire Int; 2004 Feb; 13(69):13-6. PubMed ID: 15055210
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of voriconazole for treatment of invasive fungal infections in 87 cases with hematologic malignancies].
Feng AM; Wei JY; Yu WJ
Zhonghua Xue Ye Xue Za Zhi; 2011 Jul; 32(7):473-5. PubMed ID: 22213868
[No Abstract] [Full Text] [Related]
10. Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation.
Martin T; Sharma M; Damon L; Kaplan L; Guglielmo BJ; Working M; O'Malley R; Hwang J; Linker C
Transpl Infect Dis; 2010 Feb; 12(1):45-50. PubMed ID: 19793068
[TBL] [Abstract][Full Text] [Related]
11. [Guideline for diagnosis and treatment of deep mycosis].
Kono S
Rinsho Ketsueki; 2001 Jun; 42(6):452-7. PubMed ID: 11505521
[No Abstract] [Full Text] [Related]
12. [Update on voriconazole].
Dtsch Med Wochenschr; 2003 Aug; 128(33):1738. PubMed ID: 12968630
[No Abstract] [Full Text] [Related]
13. Voriconazole treatment for less-common, emerging, or refractory fungal infections.
Perfect JR; Marr KA; Walsh TJ; Greenberg RN; DuPont B; de la Torre-Cisneros J; Just-Nübling G; Schlamm HT; Lutsar I; Espinel-Ingroff A; Johnson E
Clin Infect Dis; 2003 May; 36(9):1122-31. PubMed ID: 12715306
[TBL] [Abstract][Full Text] [Related]
14. [Therapy of invasive mycoses in neutropenic patients with hematologic system diseases].
Glasmacher A; Just-Nübling G; Molitor E
Dtsch Med Wochenschr; 1998 Feb; 123(7):191-4. PubMed ID: 9505945
[No Abstract] [Full Text] [Related]
15. Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy.
Baden LR; Katz JT; Fishman JA; Koziol C; DelVecchio A; Doran M; Rubin RH
Transplantation; 2003 Dec; 76(11):1632-7. PubMed ID: 14702539
[TBL] [Abstract][Full Text] [Related]
16. A multicentre pharmacoepidemiological study of therapeutic practices in invasive fungal infections in France during 1998-1999.
Lortholary O; Charlemagne A; Bastides F; Chevalier P; Datry A; Gonzalves MF; Michel G; Tilleul P; Veber B; Herbrecht R
J Antimicrob Chemother; 2004 Aug; 54(2):456-64. PubMed ID: 15231769
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients.
Barnes RA; White PL; Bygrave C; Evans N; Healy B; Kell J
J Clin Pathol; 2009 Jan; 62(1):64-9. PubMed ID: 19103864
[TBL] [Abstract][Full Text] [Related]
18. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.
Maertens J; Theunissen K; Verhoef G; Verschakelen J; Lagrou K; Verbeken E; Wilmer A; Verhaegen J; Boogaerts M; Van Eldere J
Clin Infect Dis; 2005 Nov; 41(9):1242-50. PubMed ID: 16206097
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy of new antifungal agents.
Kauffman CA
Curr Opin Microbiol; 2006 Oct; 9(5):483-8. PubMed ID: 16904366
[TBL] [Abstract][Full Text] [Related]
20. [Clinical picture and therapy of endemic fungal diseases (candidiasis, mucormycosis, aspergillosis)].
Wegmann T
Verh Dtsch Ges Inn Med; 1971; 77():842-50. PubMed ID: 4949705
[No Abstract] [Full Text] [Related]
[Next] [New Search]